• Western blot analysis of extracts of various cell lines, using CRHBP antibody (STJ114994) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 30s.

Anti-CRHBP antibody (221-322) (STJ114994)

SKU:
STJ114994

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CRHBP (221-322) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CRHBP
Gene ID: 1393
Uniprot ID: CRHBP_HUMAN
Immunogen Region: 221-322
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 221-322 of human CRHBP (NP_001873.2).
Immunogen Sequence: TLGHVNGLQLKKSSAGCEGI GDFVELLGGTGLDPSKMTPL ADLCYPFHGPAQMKVGCDNT VVRMVSSGKHVNRVTFEYRQ LEPYELENPNGNSIGEFCLS GL
Function Binds CRF and inactivates it. May prevent inappropriate pituitary-adrenal stimulation in pregnancy.
Protein Name Corticotropin-Releasing Factor-Binding Protein
Crf-Bp
Crf-Binding Protein
Corticotropin-Releasing Hormone-Binding Protein
Crh-Bp
Database Links Reactome: R-HSA-373080
Cellular Localisation Secreted
Alternative Antibody Names Anti-Corticotropin-Releasing Factor-Binding Protein antibody
Anti-Crf-Bp antibody
Anti-Crf-Binding Protein antibody
Anti-Corticotropin-Releasing Hormone-Binding Protein antibody
Anti-Crh-Bp antibody
Anti-CRHBP antibody
Anti-CRFBP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance